A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine
Completed · Phase 1
Conditions studied: Migraine
In brief
The purpose of the study is the measure the levels of lasmiditan in the body of children aged 6 to 17 with migraine. The study also will also examine the safety and tolerability of lasmiditan in children aged 6 to 17 with migraine. The study will last about 6 weeks, and includes 4 visits.
Key facts
- Study ID
- NCT03988088
- Run by
- Eli Lilly and Company
- People needed
- 18
- Starts
- 2019-07-22
- Expected to finish
- 2020-02-24
- Last updated by the study team
- 2020-09-01
Who can join
Age: 6 and older, up to 17. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Participants must have a history of migraine headaches for more than 6 months
- Participants must have a history of 2 to 15 migraine headaches per month in the past 2 months
- Participants must weigh between 15 and 55 kilograms (kg)
- Participants must not have a migraine headache on the day of lasmiditan administration
You may not qualify if…
- Participants must not be pregnant or nursing
- Participants must not have any acute, serious, or unstable medical condition
- Participants must not be actively suicidal or at significant risk for suicide, in the opinion of the investigator
- Participants must not be on a medicine that acts in the brain and spinal cord
Where it is running
- Perserverance Research Center — Scottsdale, Arizona, United States
- Newport Beach Clinical Research Associates, Inc. — Newport Beach, California, United States
- New England Institute for Clinical Research — Stamford, Connecticut, United States
- Meridien Research — Bradenton, Florida, United States
- Meridien Research — Maitland, Florida, United States
- Qps-Mra, Llc — South Miami, Florida, United States
- Premiere Research Institute at Palm Beach Neurology — West Palm Beach, Florida, United States
- Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States
- Kurume Clinical Pharmacology Clinic — Kurume, Fukuoka, Japan
- Clinical Research Hospital, Tokyo — Shinjuku-Ku, Tokyo, Japan
- San Jorge Children and Women's Hospital- Shipping Location — San Juan, PR, Puerto Rico
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.